BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 23893261)

  • 21. Dornase alfa for cystic fibrosis.
    Yang C; Chilvers M; Montgomery M; Nolan SJ
    Cochrane Database Syst Rev; 2016 Apr; 4():CD001127. PubMed ID: 27043279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant growth hormone therapy for cystic fibrosis in children and young adults.
    Thaker V; Haagensen AL; Carter B; Fedorowicz Z; Houston BW
    Cochrane Database Syst Rev; 2013 Jun; 6(6):CD008901. PubMed ID: 23737090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral calorie supplements for cystic fibrosis.
    Smyth RL; Rayner O
    Cochrane Database Syst Rev; 2014 Nov; (11):CD000406. PubMed ID: 25363148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pancreatic enzyme replacement therapy for people with cystic fibrosis.
    Somaraju UR; Solis-Moya A
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD008227. PubMed ID: 27878805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral anti-pseudomonal antibiotics for cystic fibrosis.
    Remmington T; Jahnke N; Harkensee C
    Cochrane Database Syst Rev; 2007 Jul; (3):CD005405. PubMed ID: 17636796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.
    Patel S; Sinha IP; Dwan K; Echevarria C; Schechter M; Southern KW
    Cochrane Database Syst Rev; 2015 Mar; (3):CD009841. PubMed ID: 25811419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macrolide antibiotics for cystic fibrosis.
    Southern KW; Barker PM; Solis-Moya A; Patel L
    Cochrane Database Syst Rev; 2011 Dec; (12):CD002203. PubMed ID: 22161368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Omega-3 fatty acids for cystic fibrosis.
    Oliver C; Jahnke N
    Cochrane Database Syst Rev; 2011 Aug; (8):CD002201. PubMed ID: 21833942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral non-steroidal anti-inflammatory drug therapy for cystic fibrosis.
    Lands LC; Stanojevic S
    Cochrane Database Syst Rev; 2007 Oct; (4):CD001505. PubMed ID: 17943753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis.
    Nash EF; Stephenson A; Ratjen F; Tullis E
    Cochrane Database Syst Rev; 2009 Jan; (1):CD007168. PubMed ID: 19160327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oscillating devices for airway clearance in people with cystic fibrosis.
    Morrison L; Agnew J
    Cochrane Database Syst Rev; 2014 Jul; (7):CD006842. PubMed ID: 25038719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pancreatic enzyme replacement therapy for people with cystic fibrosis.
    Somaraju UR; Solis-Moya A
    Cochrane Database Syst Rev; 2014 Oct; (10):CD008227. PubMed ID: 25310479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug therapies for reducing gastric acidity in people with cystic fibrosis.
    Ng SM; Moore HS
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD003424. PubMed ID: 27546383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin glargine: a systematic review of a long-acting insulin analogue.
    Wang F; Carabino JM; Vergara CM
    Clin Ther; 2003 Jun; 25(6):1541-77, discussion 1539-40. PubMed ID: 12860485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin and glucose excursion following premeal insulin lispro or repaglinide in cystic fibrosis-related diabetes.
    Moran A; Phillips J; Milla C
    Diabetes Care; 2001 Oct; 24(10):1706-10. PubMed ID: 11574430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral steroids for long-term use in cystic fibrosis.
    Cheng K; Ashby D; Smyth RL
    Cochrane Database Syst Rev; 2013 Jun; (6):CD000407. PubMed ID: 23794322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral steroids for long-term use in cystic fibrosis.
    Cheng K; Ashby D; Smyth RL
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD000407. PubMed ID: 26649765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Omega-3 fatty acids for cystic fibrosis.
    Oliver C; Watson H
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD002201. PubMed ID: 26730723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-inflammatory drugs and analgesics for managing symptoms in people with cystic fibrosis-related arthritis.
    Thornton J; Rangaraj S
    Cochrane Database Syst Rev; 2012 Mar; (3):CD006838. PubMed ID: 22419317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral steroids for long-term use in cystic fibrosis.
    Cheng K; Ashby D; Smyth RL
    Cochrane Database Syst Rev; 2011 Oct; (10):CD000407. PubMed ID: 21975730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.